We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SVA market cap is 69.77M. The company's latest EPS is CAD -0.1286 and P/E is -1.79.
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 962k | 551k | 0 | 0 | 0 |
| Operating Income | -4.01M | -5.03M | -6.62M | -24.12M | -39.66M |
| Net Income | -3.97M | -5.32M | -6.97M | -24.42M | -39M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 5.57M | 5.73M | 29.82M | 52.49M | 22.11M |
| Total Liabilities | 687k | 1.58M | 1.75M | 4.88M | 9.59M |
| Total Equity | 4.88M | 4.14M | 28.07M | 47.61M | 12.52M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -4.19M | -3.94M | -6.85M | -14.42M | -30.34M |
| Investing | -1.02M | 995k | -228k | -46.34M | 34.78M |
| Financing | 5.27M | 5.1M | 31M | 36.66M | 503k |
| Market Cap | 69.77M |
| Price to Earnings Ratio | -1.79 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.99 |
| Price to Book Ratio | 5.57 |
| Dividend Yield | - |
| Shares Outstanding | 303.33M |
| Average Volume (1 week) | 132.91k |
| Average Volume (1 Month) | 112.05k |
| 52 Week Change | -66.18% |
| 52 Week High | 0.73 |
| 52 Week Low | 0.20 |
| Spread (Intraday) | 0.01 (2.17%) |
| Company Name | Sernova Corp |
| Address |
suite 1500 - 1055 west georgia street vancouver, british columbia V6E 2N7 |
| Website | https://www.sernova.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
